The antibody trastuzumab (Herceptin), which is used to treat breast cancers that overexpress the HER2/neu protein, has been tried with some success in a phase II trial in women with UPSCs that overexpress HER2/neu.
•
In a recent study, about 60% of USCs were found to overexpress the protein HER2/neu--the same one that is overexpressed in some breast cancers.
Hepatocellular carcinoma | Uterine contraction | Squamous-cell carcinoma | squamous-cell carcinoma | Serous fluid | Renal cell carcinoma | nevoid basal cell carcinoma syndrome | Merkel cell carcinoma | Chimney sweeps' carcinoma | Carcinoma | Adrenocortical carcinoma |